These antibodies are designed on the basis of structural information about a region where all ALS-linked SOD1 mutants bind to Derlin-1, a component of the endoplasmic reticulum-associated degradation machinery [26,27]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.